Sarcomeric dysfunction contributes to muscle weakness in facioscapulohumeral muscular dystrophy

Saskia Lassche, Ger J M Stienen, Tom C. Irving, Silvère M. Van Der Maarel, Nicol C. Voermans, George W. Padberg, Hendrikus "Henk" Granzier, Baziel G M Van Engelen, Coen A C Ottenheijm

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Objective: To investigate whether sarcomeric dysfunction contributes to muscle weakness in facioscapulohumeral muscular dystrophy (FSHD). Methods: Sarcomeric function was evaluated by contractile studies on demembranated single muscle fibers obtained from quadriceps muscle biopsies of 4 patients with FSHD and 4 healthy controls. The sarcomere length dependency of force was determined together with measurements of thin filament length using immunofluorescence confocal scanning laser microscopy. X-ray diffraction techniques were used to study myofilament lattice spacing. Results: FSHD muscle fibers produced only 70% of active force compared to healthy controls, a reduction which was exclusive to type II muscle fibers. Changes in force were not due to changes in thin filament length or sarcomere length. Passive force was increased 5- to 12-fold in both fiber types, with increased calcium sensitivity of force generation and decreased myofilament lattice spacing, indicating compensation by the sarcomeric protein titin. Conclusions: We have demonstrated a reduction in sarcomeric force in type II FSHD muscle fibers, and suggest compensatory mechanisms through titin stiffening. Based on these findings, we propose that sarcomeric dysfunction plays a critical role in the development of muscle weakness in FSHD.

Original languageEnglish (US)
Pages (from-to)733-737
Number of pages5
JournalNeurology
Volume80
Issue number8
DOIs
StatePublished - Feb 19 2013

Fingerprint

Facioscapulohumeral Muscular Dystrophy
Muscle Weakness
Connectin
Sarcomeres
Myofibrils
Muscles
Fast-Twitch Muscle Fibers
Quadriceps Muscle
Confocal Microscopy
X-Ray Diffraction
Fluorescent Antibody Technique
Calcium
Biopsy
Fiber
Length
Proteins

ASJC Scopus subject areas

  • Clinical Neurology
  • Arts and Humanities (miscellaneous)

Cite this

Lassche, S., Stienen, G. J. M., Irving, T. C., Van Der Maarel, S. M., Voermans, N. C., Padberg, G. W., ... Ottenheijm, C. A. C. (2013). Sarcomeric dysfunction contributes to muscle weakness in facioscapulohumeral muscular dystrophy. Neurology, 80(8), 733-737. https://doi.org/10.1212/WNL.0b013e318282513b

Sarcomeric dysfunction contributes to muscle weakness in facioscapulohumeral muscular dystrophy. / Lassche, Saskia; Stienen, Ger J M; Irving, Tom C.; Van Der Maarel, Silvère M.; Voermans, Nicol C.; Padberg, George W.; Granzier, Hendrikus "Henk"; Van Engelen, Baziel G M; Ottenheijm, Coen A C.

In: Neurology, Vol. 80, No. 8, 19.02.2013, p. 733-737.

Research output: Contribution to journalArticle

Lassche, S, Stienen, GJM, Irving, TC, Van Der Maarel, SM, Voermans, NC, Padberg, GW, Granzier, HH, Van Engelen, BGM & Ottenheijm, CAC 2013, 'Sarcomeric dysfunction contributes to muscle weakness in facioscapulohumeral muscular dystrophy', Neurology, vol. 80, no. 8, pp. 733-737. https://doi.org/10.1212/WNL.0b013e318282513b
Lassche S, Stienen GJM, Irving TC, Van Der Maarel SM, Voermans NC, Padberg GW et al. Sarcomeric dysfunction contributes to muscle weakness in facioscapulohumeral muscular dystrophy. Neurology. 2013 Feb 19;80(8):733-737. https://doi.org/10.1212/WNL.0b013e318282513b
Lassche, Saskia ; Stienen, Ger J M ; Irving, Tom C. ; Van Der Maarel, Silvère M. ; Voermans, Nicol C. ; Padberg, George W. ; Granzier, Hendrikus "Henk" ; Van Engelen, Baziel G M ; Ottenheijm, Coen A C. / Sarcomeric dysfunction contributes to muscle weakness in facioscapulohumeral muscular dystrophy. In: Neurology. 2013 ; Vol. 80, No. 8. pp. 733-737.
@article{66d8a45c0fea4c3a90653cbca1271588,
title = "Sarcomeric dysfunction contributes to muscle weakness in facioscapulohumeral muscular dystrophy",
abstract = "Objective: To investigate whether sarcomeric dysfunction contributes to muscle weakness in facioscapulohumeral muscular dystrophy (FSHD). Methods: Sarcomeric function was evaluated by contractile studies on demembranated single muscle fibers obtained from quadriceps muscle biopsies of 4 patients with FSHD and 4 healthy controls. The sarcomere length dependency of force was determined together with measurements of thin filament length using immunofluorescence confocal scanning laser microscopy. X-ray diffraction techniques were used to study myofilament lattice spacing. Results: FSHD muscle fibers produced only 70{\%} of active force compared to healthy controls, a reduction which was exclusive to type II muscle fibers. Changes in force were not due to changes in thin filament length or sarcomere length. Passive force was increased 5- to 12-fold in both fiber types, with increased calcium sensitivity of force generation and decreased myofilament lattice spacing, indicating compensation by the sarcomeric protein titin. Conclusions: We have demonstrated a reduction in sarcomeric force in type II FSHD muscle fibers, and suggest compensatory mechanisms through titin stiffening. Based on these findings, we propose that sarcomeric dysfunction plays a critical role in the development of muscle weakness in FSHD.",
author = "Saskia Lassche and Stienen, {Ger J M} and Irving, {Tom C.} and {Van Der Maarel}, {Silv{\`e}re M.} and Voermans, {Nicol C.} and Padberg, {George W.} and Granzier, {Hendrikus {"}Henk{"}} and {Van Engelen}, {Baziel G M} and Ottenheijm, {Coen A C}",
year = "2013",
month = "2",
day = "19",
doi = "10.1212/WNL.0b013e318282513b",
language = "English (US)",
volume = "80",
pages = "733--737",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - Sarcomeric dysfunction contributes to muscle weakness in facioscapulohumeral muscular dystrophy

AU - Lassche, Saskia

AU - Stienen, Ger J M

AU - Irving, Tom C.

AU - Van Der Maarel, Silvère M.

AU - Voermans, Nicol C.

AU - Padberg, George W.

AU - Granzier, Hendrikus "Henk"

AU - Van Engelen, Baziel G M

AU - Ottenheijm, Coen A C

PY - 2013/2/19

Y1 - 2013/2/19

N2 - Objective: To investigate whether sarcomeric dysfunction contributes to muscle weakness in facioscapulohumeral muscular dystrophy (FSHD). Methods: Sarcomeric function was evaluated by contractile studies on demembranated single muscle fibers obtained from quadriceps muscle biopsies of 4 patients with FSHD and 4 healthy controls. The sarcomere length dependency of force was determined together with measurements of thin filament length using immunofluorescence confocal scanning laser microscopy. X-ray diffraction techniques were used to study myofilament lattice spacing. Results: FSHD muscle fibers produced only 70% of active force compared to healthy controls, a reduction which was exclusive to type II muscle fibers. Changes in force were not due to changes in thin filament length or sarcomere length. Passive force was increased 5- to 12-fold in both fiber types, with increased calcium sensitivity of force generation and decreased myofilament lattice spacing, indicating compensation by the sarcomeric protein titin. Conclusions: We have demonstrated a reduction in sarcomeric force in type II FSHD muscle fibers, and suggest compensatory mechanisms through titin stiffening. Based on these findings, we propose that sarcomeric dysfunction plays a critical role in the development of muscle weakness in FSHD.

AB - Objective: To investigate whether sarcomeric dysfunction contributes to muscle weakness in facioscapulohumeral muscular dystrophy (FSHD). Methods: Sarcomeric function was evaluated by contractile studies on demembranated single muscle fibers obtained from quadriceps muscle biopsies of 4 patients with FSHD and 4 healthy controls. The sarcomere length dependency of force was determined together with measurements of thin filament length using immunofluorescence confocal scanning laser microscopy. X-ray diffraction techniques were used to study myofilament lattice spacing. Results: FSHD muscle fibers produced only 70% of active force compared to healthy controls, a reduction which was exclusive to type II muscle fibers. Changes in force were not due to changes in thin filament length or sarcomere length. Passive force was increased 5- to 12-fold in both fiber types, with increased calcium sensitivity of force generation and decreased myofilament lattice spacing, indicating compensation by the sarcomeric protein titin. Conclusions: We have demonstrated a reduction in sarcomeric force in type II FSHD muscle fibers, and suggest compensatory mechanisms through titin stiffening. Based on these findings, we propose that sarcomeric dysfunction plays a critical role in the development of muscle weakness in FSHD.

UR - http://www.scopus.com/inward/record.url?scp=84876210853&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876210853&partnerID=8YFLogxK

U2 - 10.1212/WNL.0b013e318282513b

DO - 10.1212/WNL.0b013e318282513b

M3 - Article

C2 - 23365058

AN - SCOPUS:84876210853

VL - 80

SP - 733

EP - 737

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 8

ER -